Leukemic cell with a novel kinase fusion gene SPAG9-JAK2 exhibits high sensitivity to ruxolitinib

Azusa Mayumi

Presentation information

Oral Session

Oral Session 1-12A ALL: Basic (1)

Fri. Oct 11, 2019 9:00 AM - 10:00 AM No.12 (Tokyo International Forum, 5F G510)

Chair: Masatoshi Takagi (Department of Developmental Biology and Pediatrics)

[OS1-12A-2] Leukemic cell with a novel kinase fusion gene SPAG9-JAK2 exhibits high sensitivity to ruxolitinib

Azusa Mayumi¹, Toshihiro Tomii¹, Toshihiko Imamura¹, Machiko Kawamura², Hajime Hosoi¹ (1.Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan, 2.Department of Hematology, Saitama Cancer Center, Saitama, Japan)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.